Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2024 09:00 ET | Source: Alira Health

Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market

Framingham, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm dedicated to humanizing life sciences, today announced the release of its 2024 Global...
July 24, 2023 07:34 ET | Source: Market Research Future

Biosimilar Contract Manufacturing Market Size to Hit USD 26.1 Billion by 2032 at 18.90% CAGR – Report by Market Research Future (MRFR)

New York, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Biosimilar Contract Manufacturing Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biosimilar...
April 06, 2023 06:44 ET | Source: InsightAce Analytic Pvt. LTd.

Adalimumab Biosimilar Market Expand Lucratively & Grow at a CAGR of 23.2% to 2031 | Says Latest InsightAce Study

Jersey City, NJ, April 06, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Adalimumab Biosimilar Market- (By Product...
January 03, 2023 09:02 ET | Source: Research Dive

Global Biosimilar Market to Gather $83,836.40 Million by 2028, Growing at a CAGR of 24.90% in the 2021-2028 Timeframe [170-Pages] | Issued by Research Dive

New York, USA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global biosimilar market is expected to gather a revenue of $83,836.40 million by...
March 29, 2022 09:00 ET | Source: Research Dive

Global Biosimilar Market to Generate a Revenue of $83,836.40 Million by 2028, Growing at a CAGR of 24.90% from 2021 to 2028 | Exclusively Available [170-Pages] by Research Dive

New York, USA, March 29, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global biosimilar market is expected to garner a revenue of $83,836.40 million by 2028,...